secwatch.observer — SEC 8-K summary
======================================

Issuer:     BriaCell Therapeutics Corp. (BCTX)
CIK:        0001610820
Form:       8-K
Filed at:   2024-10-02T23:59:59+00:00
Accession:  0001493152-24-039218
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BriaCell closes $5M offering of 5.1M shares and warrants at $0.975/unit
-----------------------------------------------------------------------

- 5,128,500 common shares and warrants to purchase 5,128,500 common shares sold at $0.975 per unit.
- Gross proceeds ~$5M; warrants exercisable at $0.85/share for five years from issuance.
- Proceeds for working capital, general corporate purposes, and business advancement.
- ThinkEquity acted as sole placement agent; placement agent warrants issued.
- Offering closed October 2, 2024, under effective shelf registration statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610820/000149315224039218/0001493152-24-039218-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610820/000149315224039218/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-039218

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer